tiprankstipranks
Trending News
More News >
Niks Professional Ltd. (SG:NPL)
SGX:NPL
Singapore Market

Niks Professional Ltd. (NPL) AI Stock Analysis

Compare
0 Followers

Top Page

SG:NPL

Niks Professional Ltd.

(SGX:NPL)

Select Model
Select Model
Select Model
Neutral 65 (OpenAI - 4o)
Rating:65Neutral
Price Target:
S$0.25
▲(7.39% Upside)
Niks Professional Ltd. benefits from strong financial performance, with robust revenue growth and profitability. However, technical indicators suggest caution due to overbought conditions, and valuation metrics are moderate. The absence of recent earnings call insights or notable corporate events limits further assessment.
Positive Factors
Revenue Growth
The significant revenue growth indicates robust business expansion and strong demand for NPL's services, enhancing its market position.
Cash Flow Generation
Strong cash flow generation supports operational flexibility and potential reinvestment in growth opportunities, ensuring long-term sustainability.
Profitability
High profitability margins reflect efficient cost management and competitive pricing power, contributing to financial stability and growth potential.
Negative Factors
Delisting Proposal
The proposed delisting could reduce market visibility and liquidity for investors, impacting shareholder value and access to capital markets.
Net Profit Margin Decline
A declining net profit margin may signal rising costs or increased competition, potentially affecting future profitability and financial health.
Free Cash Flow to Net Income Ratio
A declining free cash flow to net income ratio could indicate challenges in maintaining cash flow health, impacting long-term financial flexibility.

Niks Professional Ltd. (NPL) vs. iShares MSCI Singapore ETF (EWS)

Niks Professional Ltd. Business Overview & Revenue Model

Company DescriptionNiks Professional Ltd., together with its subsidiaries, provides family practice dermatology and aesthetic medical services under the NIKS brand in Singapore. The company operates through three segments: Clinics, Retail, and Headquarters. It offers treatment for acne and acne scars, eczema, and pigmentation, as well as non-invasive and minimally invasive aesthetic medical services, including intense pulsed light treatment, various laser treatments, and injectables. The company also sells a range of medical skincare products to hospitals, clinics, pharmacies, retail shops, doctors, and consumers through regional agents, as well as through own channels, and online sale and distribution. In addition, it provides salon services, such as therapeutic facial treatment, eye treatment, acne and comedone treatment, and microdermabrasion. The company was incorporated in 1998 and is headquartered in Singapore.
How the Company Makes MoneyNPL generates revenue through multiple streams, primarily by charging clients for consultancy services based on hourly rates or project-based fees. Additionally, the company earns income from long-term contracts with businesses seeking ongoing support for their IT systems and processes. Key revenue streams include subscription fees for proprietary software tools developed by NPL, which help clients streamline their operations. Significant partnerships with technology providers allow NPL to offer bundled services, enhancing its value proposition and attracting more clients. The company's focus on delivering high-quality, tailored solutions has contributed to its reputation and repeat business, further solidifying its financial performance.

Niks Professional Ltd. Financial Statement Overview

Summary
Niks Professional Ltd. shows strong financial health with impressive revenue growth and profitability. The balance sheet is stable with low leverage and strong equity backing. Cash flow generation is robust, though maintaining free cash flow levels requires attention.
Income Statement
Niks Professional Ltd. has demonstrated strong revenue growth with a 107.34% increase in the latest year, indicating robust business expansion. The company maintains high profitability with a gross profit margin of 83.79% and a net profit margin of 18.58%, showcasing efficient cost management. However, the net profit margin has slightly decreased from previous years, which could indicate rising costs or competitive pressures.
Balance Sheet
The balance sheet reflects a solid financial position with a low debt-to-equity ratio of 0.078, indicating prudent leverage management. The return on equity is healthy at 10.30%, although it has decreased from previous years, suggesting potential challenges in generating returns. The equity ratio of 85.91% underscores strong asset backing by equity, enhancing financial stability.
Cash Flow
Cash flow analysis reveals a significant improvement in free cash flow growth at 144.49%, indicating enhanced cash generation capabilities. The operating cash flow to net income ratio of 1.09 suggests effective conversion of earnings into cash. However, the free cash flow to net income ratio has decreased, which may warrant attention to ensure sustained cash flow health.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue11.27M11.19M10.85M11.10M11.70M11.19M
Gross Profit3.22M9.38M3.73M4.17M4.29M4.03M
EBITDA3.46M3.58M3.04M4.15M5.13M4.71M
Net Income1.94M2.08M1.69M2.76M3.34M3.00M
Balance Sheet
Total Assets22.29M23.49M22.63M25.78M26.85M29.71M
Cash, Cash Equivalents and Short-Term Investments8.43M9.18M9.09M12.37M13.26M17.04M
Total Debt1.23M1.57M1.43M1.36M1.41M226.00K
Total Liabilities2.72M3.31M3.25M3.46M3.43M2.38M
Stockholders Equity19.57M20.18M19.38M22.12M23.19M27.12M
Cash Flow
Free Cash Flow2.29M1.75M1.89M3.32M4.10M4.71M
Operating Cash Flow2.71M2.56M2.19M3.39M4.41M4.97M
Investing Cash Flow-420.00K-547.00K-169.00K-47.00K-311.00K-267.00K
Financing Cash Flow-2.04M-1.96M-5.31M-4.20M-7.91M-469.00K

Niks Professional Ltd. Technical Analysis

Technical Analysis Sentiment
Positive
Last Price0.23
Price Trends
50DMA
0.22
Positive
100DMA
0.22
Positive
200DMA
0.20
Positive
Market Momentum
MACD
<0.01
Negative
RSI
74.23
Negative
STOCH
100.00
Negative
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SG:NPL, the sentiment is Positive. The current price of 0.23 is above the 20-day moving average (MA) of 0.23, above the 50-day MA of 0.22, and above the 200-day MA of 0.20, indicating a bullish trend. The MACD of <0.01 indicates Negative momentum. The RSI at 74.23 is Negative, neither overbought nor oversold. The STOCH value of 100.00 is Negative, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SG:NPL.

Niks Professional Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (51)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
S$164.79M9.8413.44%1.84%13.35%20.00%
71
Outperform
S$22.42M8.857.31%3.33%-0.73%100.00%
65
Neutral
S$29.90M15.4410.05%4.35%3.04%27.35%
53
Neutral
S$528.46M45.381.18%6.34%160.00%
51
Neutral
$7.86B-0.30-43.30%2.27%22.53%-2.21%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SG:NPL
Niks Professional Ltd.
0.23
0.11
91.67%
SG:5EV
Hosen Group Ltd.
0.07
0.03
60.47%
SG:5HV
Koh Brothers Eco Engineering Limited
0.08
0.05
130.56%
SG:F83
COSCO Shipping International Singapore Co Ltd
0.12
-0.02
-13.24%
SG:MF6
Mun Siong Engineering Ltd.
0.03
<0.01
25.93%
SG:MR7
Nordic Group Limited
0.43
0.10
31.17%

Niks Professional Ltd. Corporate Events

Niks Professional Moves Into Final Stages of Delisting via Selective Capital Reduction
Jan 8, 2026

Niks Professional Ltd. has provided an update on its planned delisting from the Singapore Exchange by way of a selective capital reduction, referring shareholders to a series of earlier announcements and a circular issued in late 2025. The company confirms that the delisting process is advancing through the necessary shareholder, court and regulatory milestones, including court approval of the selective capital reduction, record date determination and suspension of trading, signalling that it is in the final stages of exiting the public market and effecting the capital reduction for its shareholders.

The most recent analyst rating on (SG:NPL) stock is a Hold with a S$0.25 price target. To see the full list of analyst forecasts on Niks Professional Ltd. stock, see the SG:NPL Stock Forecast page.

Niks Professional Wins Court Nod for Selective Capital Reduction Ahead of Delisting
Dec 18, 2025

Niks Professional Ltd. has obtained court approval for its proposed selective capital reduction, a key step in its plan to delist from the Singapore market via this mechanism. With no additional conditions imposed by the court, the capital reduction will become effective upon the company’s lodgement of the court order and required documents with the corporate regulator, after which the firm will announce the record date, marking the next milestone in returning capital to selected shareholders and advancing its delisting process.

The most recent analyst rating on (SG:NPL) stock is a Hold with a S$0.25 price target. To see the full list of analyst forecasts on Niks Professional Ltd. stock, see the SG:NPL Stock Forecast page.

Niks Professional Ltd. Faces Shareholder Queries on Delisting Decision
Nov 19, 2025

Niks Professional Ltd. has received questions from a shareholder regarding its decision to delist from the stock market, despite being profitable and operating in the promising healthcare sector. The Board has decided that delisting via a selective capital reduction route is an immediate solution for shareholders, considering the historical trading performance and compliance costs. The Board also addressed concerns about minority shareholders’ interests and the exploration of other corporate actions before deciding on delisting.

Niks Professional Ltd. Announces EGM and Delisting Plans
Nov 4, 2025

Niks Professional Ltd. has announced the electronic dissemination of a circular related to its extraordinary general meeting (EGM) scheduled for November 27, 2025. This meeting will address the proposed delisting through selective capital reduction. The circular, available on SGXNet and the company’s website, provides shareholders with details about the proposed transactions and recommendations from the Independent Financial Advisor and Recommending Directors. The EGM will be held physically, and shareholders can appoint proxies to vote on their behalf, as virtual participation is not an option.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Oct 29, 2025